Prevalence and clinical profile of microcephaly in South America pre-Zika, 2005-14: prevalence and case-control study

Iêda M Orioli1,2, Helen Dolk3, Jorge S Lopez-Camelo2,4

  • 1Latin American Collaborative Study of Congenital Malformations (ECLAMC) at Department of Genetics, Institute of Biology, Federal University of Rio de Janeiro, 21944-001, Rio de Janeiro, Brazil.

BMJ (Clinical Research Ed.)
|November 23, 2017
PubMed

Insights

Microcephaly prevalence in South America before the 2015 Zika epidemic was estimated at 3.0-4.4 per 10,000 births. Endemic infections and genetic factors were significant causes, highlighting the need for ongoing surveillance.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Genetics

Background:

  • Microcephaly is a critical indicator of potential developmental abnormalities.
  • Establishing baseline prevalence before the Zika epidemic is crucial for future public health surveillance.
  • Understanding the clinical spectrum of microcephaly aids in identifying diverse etiologies.

Purpose of the Study:

  • To determine the prevalence and clinical characteristics of microcephaly in South America from 2005-2014.
  • To establish a baseline for microcephaly surveillance prior to the Zika virus epidemic.
  • To identify common causes and clinical presentations of microcephaly in the region.

Main Methods:

  • A prevalence and case-control study design was employed.
  • Data were sourced from the ECLAMC database (Latin American Collaborative Study of Congenital Malformations) across 10 South American countries (2005-2014).
  • Hospital-based and population-based prevalence were calculated, with head circumference data compared to Intergrowth charts for cases from 2010-2014.

Main Results:

  • A total of 552 microcephaly cases were registered, with hospital-based prevalence at 4.4/10,000 births and population-based prevalence at 3.0/10,000 births.
  • Significant variations in prevalence were observed across countries, regions, and hospitals.
  • Common associations included diagnosed genetic syndromes (23%), polymalformations without syndrome diagnosis (34%), neural malformations (12%), and STORCH infections (3.8%).

Conclusions:

  • An estimated 2000-2500 microcephaly cases occurred annually in South America before 2015.
  • Diagnosis of microcephaly involves more than simple head circumference measurements.
  • Endemic infections represent important, persistent causes of microcephaly, necessitating continued monitoring.